---
title: "Menatetrenone - Hemorrhagic Disease Of The Newborn Due To Vitamin K Deficiency"
sidebar: mydoc_sidebar
permalink: db12148-mesh-d006475-1.html
toc: false 
---


Path ID: `DB12148_MESH_D006475_1`
{% include image.html url="images/db12148-mesh-d006475-1.png" file="db12148-mesh-d006475-1.png" alt="db12148-mesh-d006475-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:C030814 | Menatetrenone | Drug |
| UniProt:P38435 | Vitamin K-dependent gamma-carboxylase | Protein |
| GO:0007596 | Blood coagulation | BiologicalProcess |
| MESH:D006475 | Hemorrhagic disease of the newborn due to vitamin K deficiency | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Menatetrenone | INCREASES ACTIVITY OF | Vitamin K-Dependent Gamma-Carboxylase |
| Vitamin K-Dependent Gamma-Carboxylase | POSITIVELY REGULATES | Blood Coagulation |
| Blood Coagulation | NEGATIVELY CORRELATED WITH | Hemorrhagic Disease Of The Newborn Due To Vitamin K Deficiency |
|---------|-----------|---------|

Reference: 
  - [https://en.wikipedia.org/wiki/Vitamin_K2#Mechanism_of_action](https://en.wikipedia.org/wiki/Vitamin_K2#Mechanism_of_action)
